Dr. Nancy A. Krywonis, MD

Dr. Krywonis practices at Cherry Creek Dermatology in Denver, Colorado.

Dr. Krywonis' NPI, 1134260466, was assigned on February 9, 2007. Dr. Krywonis graduated from University of Manitoba, Faculty of Medicine in 1984. Dr. Krywonis holds Colorado license 44212.

Dr. Krywonis' primary practice is Cherry Creek Dermatology, at 3773 E Cherry Creek North Dr, Denver, CO 80209 in Denver County. The practice phone is (303) 388-5629.

Dr. Krywonis' primary practice is Cherry Creek Dermatology in Denver, Colorado. The medical group on file is Epiphany Dermatology. Dmand AI also links Dr. Krywonis to 2 more group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Krywonis practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Krywonis' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Krywonis is licensed in Colorado.

CMS data shows 1,922 Medicare services from Dr. Krywonis across 10 procedure codes in 2024, for 692 Medicare patients. Medicare paid $89,300 for them. Every service was in an office.

CMS counts 692 Medicare patients who saw Dr. Krywonis in 2024. The largest group is 65 to 74, with 328 patients. 71% of them have high cholesterol, and 52% have high blood pressure. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Krywonis' median patient age at 70, with 63% women.

In 2024, Dr. Krywonis wrote 221 Medicare Part D claims for 137 patients. 88% of them were for generic drugs. CMS names the drug for 126 of them, across 6 drugs with 11 or more claims each, at $2,663 in total drug cost. In 2023, CMS named 175 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Krywonis for performance year 2024, reported as part of a group. Dr. Krywonis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 207 procedures of removal of skin lesions by Dr. Krywonis, more than 79% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Krywonis to 4 clinical trials, 2 of them phase 2 studies. Conditions studied include Acneiform Eruptions and Acne Vulgaris. Open Payments lists research payments to Dr. Krywonis that name 1 trial.

CMS Open Payments shows 65 general payments to Dr. Krywonis from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Sun Pharmaceutical Industries Inc. paid the most, $202. It also lists 15 research payments totaling $115,638 from 2016 to 2018, naming 1 clinical trial.

Dr. Krywonis graduated from University of Manitoba, Faculty of Medicine in 1984.